おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Alebund Pharmaceuticals
company
About
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $60M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2018
- Operating Status
- Active
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$114.50M
Alebund Pharmaceuticals has raised a total of
$114.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 13, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 13, 2021 | Series B | $54.50M | 1 | — | — | Detail |
| May 9, 2021 | Series B | $60M | 1 | — | — | Detail |
| Jan 1, 2020 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Alebund Pharmaceuticals is funded by 1 investors.
Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lilly Asia Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
